Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2018
At a glance
- Drugs Onalespib (Primary)
- Indications Anaplastic large cell lymphoma; Diffuse large B cell lymphoma; Mantle-cell lymphoma
- Focus Pharmacodynamics; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 17 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2019.
- 15 Dec 2016 Planned number of patients changed from 34 to 50.